Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.45B | 24.38B | 23.86B | 23.95B | 23.22B | 22.50B |
Gross Profit | 8.43B | 8.68B | 7.29B | 9.27B | 10.02B | 9.53B |
EBITDA | 2.49B | 2.87B | 1.66B | 2.72B | 4.18B | 4.59B |
Net Income | 1.30B | 1.51B | 603.18M | 1.44B | 2.05B | 2.46B |
Balance Sheet | ||||||
Total Assets | 21.05B | 21.18B | 22.70B | 21.30B | 20.83B | 20.47B |
Cash, Cash Equivalents and Short-Term Investments | 12.47B | 12.83B | 13.84B | 13.20B | 12.94B | 11.93B |
Total Debt | 7.00M | 6.66M | 9.91M | 13.99M | 8.68M | 57.97M |
Total Liabilities | 7.23B | 6.94B | 8.48B | 6.56B | 6.09B | 6.43B |
Stockholders Equity | 13.82B | 14.24B | 14.22B | 14.74B | 14.75B | 14.04B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 987.74M | 1.96B | 1.62B | 2.35B | 3.76B |
Operating Cash Flow | 0.00 | 1.21B | 2.28B | 2.20B | 3.24B | 4.09B |
Investing Cash Flow | 0.00 | -267.84M | -759.16M | -565.77M | -865.46M | -306.41M |
Financing Cash Flow | 0.00 | -1.46B | -1.46B | -1.46B | -1.50B | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥27.17B | 12.21 | 4.72% | 2.50% | -1.49% | ||
81 Outperform | ¥26.63B | 13.03 | 5.06% | 13.49% | 24.79% | ||
77 Outperform | ¥29.12B | 21.78 | 0.78% | 17.50% | 16.98% | ||
73 Outperform | ¥28.24B | 23.11 | 0.62% | 10.35% | 98.15% | ||
72 Outperform | ¥29.48B | 19.58 | 4.95% | 2.17% | 149.68% | ||
67 Neutral | ¥34.81B | 111.30 | ― | 12.79% | 10.87% | ||
56 Neutral | $3.18B | 5.08 | -5.68% | 5.65% | 8.05% | -41.83% |